BCR ABL MAJOR P210
BCR210
Test Summary
It is a quantitative test for BCR-ABL major breakpoint (p210, e14a2/b3a2). It utilizes a nested PCR method for the detection of the BCR-ABL target gene and ABL reference gene. Quantitative results are converted to an International Scale (IS) percentage. The clinically demonstrated limit of detection of IS is 0.005% - 50%.
Aliases
BCR ABL1 Gene Rearragement-Major
Specimen Collection
Special Instructions
N/A
Preferred Specimen
Minimum Volume
4mL whole blood and 3 mL Bone marrow
Instructions
Patient Preparation
N/A
Storage
EDTA (lavender-top) tube
Transport Temperature
Room temperature
Specimen Stability
- Room temperature:24-48 hours days
- Refrigerated: 7 days
- Frozen: 7 days
Limitations
N/A
Other Acceptable Specimens
N/A
Unacceptable Specimens
Frozen samples, insufficient sample volume, improper storage conditions, exceeds specimen stability guidelines
Order Code
BCR210
EPIC (Premier) Code
LAB6941
Includes
N/A
CPT Code
81206
Billing Code
300120
CPT Statement
Methodology
Quantitative Real-Time Polymerase Chain Reaction (PCR)
FDA Status
FDA Approved
Physician Attestation of Informed Consent
N/A
Testing Laboratory
Department
Reference Range
See Laboratory Report
Setup Schedule / Expected Turnaround Time
Monday - Friday; Report available: 5 days
Specimen Collection
Special Instructions
N/A
Preferred Specimen
Minimum Volume
4mL whole blood and 3 mL Bone marrow
Instructions
Patient Preparation
N/A
Storage
EDTA (lavender-top) tube
Transport Temperature
Room temperature
Specimen Stability
- Room temperature:24-48 hours days
- Refrigerated: 7 days
- Frozen: 7 days
Limitations
N/A
Other Acceptable Specimens
N/A
Unacceptable Specimens
Frozen samples, insufficient sample volume, improper storage conditions, exceeds specimen stability guidelines
Result Information
Methodology
Quantitative Real-Time Polymerase Chain Reaction (PCR)
Testing Laboratory
Reference Range
See Laboratory Report
Setup Schedule / Expected Turnaround Time
Monday - Friday; Report available: 5 days